
The study investigated the potential of the Albumin to Fibrinogen Ratio (AFR) as a predictive marker for mortality in Hypertrophic Cardiomyopathy (HCM) patients. Analyzing 404 adult HCM patients over a median 4.75-year follow-up, it found that those in the low AFR group had a significantly higher incidence of HCM-related death, with an unadjusted hazard ratio of 2.97 and an adjusted hazard ratio of 3.15, compared to the high AFR group. This relationship remained independent of other variables after adjustments. The findings suggest that AFR is an independent prognostic factor, indicating that lower AFR in adult HCM patients correlates with an increased risk of HCM-related death.
Like
Save
Share